Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2025	Sep. 30, 2024
Cash flows from operating activities:
Net loss	$ (9,892,157)	$ (8,321,698)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation	143,182	161,568
Share-based compensation	2,108,226	1,420,178
Loss on disposal of assets	169,291
Gain on deconsolidation		(185,352)
Gain on forgiveness of liability		(1,788,204)
Change in fair value of related party note	725,932	350,355
Interest accrued on related party note	74,722	54,167
Changes in operating assets and liabilities:
Prepaid expenses	(6,436)	(183,167)
Accounts payable	959,305	(1,556,563)
Accrued liabilities and other current liabilities	136,939	390,524
Other operating assets and liabilities	1,729,554	1,830,383
Net cash used in operating activities	(3,851,442)	(7,827,809)
Cash flows from financing activities:
Net proceeds from sale of equity	13,137,498
Proceeds from issuance of related party note		5,000,000
Proceeds from sale of shares in private placement		5,800,000
Proceeds from employee stock purchases and option exercises	409,296	19,989
Net cash provided by financing activities	13,546,794	10,819,989
Effect of exchange rate changes on cash	8,820	(31,170)
Net increase in cash and cash equivalents	9,704,172	2,961,010
Cash and cash equivalents, beginning of period	4,577,040	3,367,229
Cash and cash equivalents, end of period	14,281,212	6,328,239
Supplemental cash flow information:
Cash paid for interest	6,163	9,027
Supplemental disclosures - non-cash activities:
Issuance of stock options for payment of certain employee bonuses		1,031,908
Issuance of related party note		$ 792,878
Employee Bonus
Supplemental disclosures - non-cash activities:
Issuance of common stock, $0.00001 par value, for payment of certain employee bonuses	$ 370,575